The syrup launched by company's Chezgreen division is designed to provide supportive care in managing common menstrual concerns such as amenorrhea, dysmenorrhea, and menorrhagia
Hikal’s Q4 profit remained sharply lower year-on-year, falling 71% from Rs. 50.2 crore in Q4 FY25 as the company absorbed regulatory pressures and strategic accounting adjustments
Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress
The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs
Honoured for his immense contribution in the field of social service and organ donation awareness
As per National Health Accounts (NHA) estimates, government health expenditure rose steadily between 2013-14 and 2022-23, while out-of-pocket spending declined significantly
Under the new initiative, each company takes on a defined role across the recycling chain
For the full year, standalone gross revenue crossed Rs. 1,700 crore
The finance leader and investment banking veteran to steer global financial strategy, investor relations, and growth initiatives
POSEIDON is among the largest global datasets to quantify this residual inflammatory burden
Subscribe To Our Newsletter & Stay Updated
